Formulation of Polymeric Nanoparticles of Antidepressant Drug for Intranasal Delivery

References

• Friedman ES , AndersonIM , ArnoneD , DenkoT. Handbook of Studies on Depression. Springer Healthcare, Tarporley, UK (2014).
   Google Scholar
• Manikandan S . Agomelatine: a novel melatonergic antidepressant. J. Pharmacol. Pharmacother.1(2), 122 (2010).
   PubMedGoogle Scholar
• Kennedy SH , EisfeldBS. Agomelatine and its therapeutic potential in the depressed patient. Neuropsychiatr. Dis. Treat.3(4), 423 (2007).
   PubMedGoogle Scholar
• Loo H , DaleryJ , MacherJ , PayenA. Pilot study comparing in blind the therapeutic effect of two doses of agomelatine, melatonin-agonist and selective 5HT2c receptors antagonist, in the treatment of major depressive disorders. L’Encephale.29(2), 165–171 (2003).
   PubMed Web of Science ®Google Scholar
• Sarkar MA . Drug metabolism in the nasal mucosa. Pharm. Res.9(1), 1–9 (1992).
   PubMed Web of Science ®Google Scholar
• Danhier F , AnsorenaE , SilvaJM , CocoR , LeBreton A , PréatV. PLGA-based nanoparticles: an overview of biomedical applications. J. Control. Release161(2), 505–522 (2012).
   PubMed Web of Science ®Google Scholar
• Kumari A , YadavSK , YadavSC. Biodegradable polymeric nanoparticles based drug delivery systems. Colloids Surf. B Biointerfaces75(1), 1–18 (2010).
   PubMed Web of Science ®Google Scholar
• Vert M , MauduitJ , LiS. Biodegradation of PLA/GA polymers: increasing complexity. Biomaterials15(15), 1209–1213 (1994).
   PubMed Web of Science ®Google Scholar
• Prokop A , DavidsonJM. Nanovehicular intracellular delivery systems. J. Pharm. Sci.97(9), 3518–3590 (2008).
   PubMed Web of Science ®Google Scholar
• Ceña V , JátivaP. Nanoparticle crossing of blood–brain barrier: a road to new therapeutic approaches to central nervous system diseases. 13, 1513–1516 (2018).
   Google Scholar
• Ong W-Y , ShaliniS-M , CostantinoL. Nose-to-brain drug delivery by nanoparticles in the treatment of neurological disorders. Curr. Med. Chem.21(37), 4247–4256 (2014).
   PubMed Web of Science ®Google Scholar
• Warnken ZN , SmythHD , WattsAB , WeitmanS , KuhnJG , WilliamsIii RO. Formulation and device design to increase nose to brain drug delivery. J. Drug Deliv. Sci. Technol.35, 213–222 (2016).
   Web of Science ®Google Scholar
• Phukan K , NandyM , SharmaRB , SharmaHK. Nanosized drug delivery systems for direct nose to brain targeting: a review. Recent Pat. Drug Delivery Formulation10(2), 156–164 (2016).
   PubMedGoogle Scholar
• Liu Q , ZhangQ. Nanoparticle systems for nose-to-brain delivery. In: Brain Targeted Drug Delivery System. HuileGao, XiaolingGao ( Eds). Elsevier Academic Press, London, UK, 219–239 (2019).
   Google Scholar
• Sharma D , SharmaRK , SharmaNet al. Nose-to-brain delivery of PLGA-diazepam nanoparticles. AAPS PharmSciTech16(5), 1108–1121 (2015).
   PubMed Web of Science ®Google Scholar
• de Oliveira Junior ER , NascimentoTL , SalomãoMA , da SilvaACG , ValadaresMC , LimaEM. Increased nose-to-brain delivery of melatonin mediated by polycaprolactone nanoparticles for the treatment of glioblastoma. Pharm. Res.36(9), 131 (2019).
   PubMed Web of Science ®Google Scholar
• Joshi SA , ChavhanSS , SawantKK. Rivastigmine-loaded PLGA and PBCA nanoparticles: preparation, optimization, characterization, in vitro and pharmacodynamic studies. Eur. J. Pharm. Biopharm.76(2), 189–199 (2010).
   PubMed Web of Science ®Google Scholar
• Seju U , KumarA , SawantK. Development and evaluation of olanzapine-loaded PLGA nanoparticles for nose-to-brain delivery: in vitro and in vivo studies. Acta Biomater.7(12), 4169–4176 (2011).
   PubMed Web of Science ®Google Scholar
• Govender T , StolnikS , GarnettMC , IllumL , DavisSS. PLGA nanoparticles prepared by nanoprecipitation: drug loading and release studies of a water soluble drug. J. Control. Release57(2), 171–185 (1999).
   PubMed Web of Science ®Google Scholar
• Christoper GP , RaghavanCV , SiddharthK , KumarMSS , PrasadRH. Formulation and optimization of coated PLGA–Zidovudine nanoparticles using factorial design and in vitroin vivo evaluations to determine brain targeting efficiency. Saudi Pharm. J.22(2), 133–140 (2014).
   PubMed Web of Science ®Google Scholar
• Shirakura T . Fractional factorial designs of two and three levels. Discrete Mathematics116(1–3), 99–135 (1993).
   Web of Science ®Google Scholar
• Yadav KS , SawantKK. Modified nanoprecipitation method for preparation of cytarabine-loaded PLGA nanoparticles. AAPS PharmSciTech11(3), 1456–1465 (2010).
   PubMed Web of Science ®Google Scholar
• Gibson M . Pharmaceutical Preformulation and Formulation: a Practical Guide from Candidate Drug Selection to Commercial Dosage Form. CRC Press, FL, USA (2016).
   Google Scholar
• Sun S-B , LiuP , ShaoF-M , MiaoQ-L. Formulation and evaluation of PLGA nanoparticles loaded capecitabine for prostate cancer. Int. J. Clin. Exp. Med.8(10), 19670 (2015).
   PubMed Web of Science ®Google Scholar
• Margulis-Goshen K , MagdassiS. Formation of simvastatin nanoparticles from microemulsion. Nanomed. Nanotechnol. Biol. Med.5(3), 274–281 (2009).
   PubMed Web of Science ®Google Scholar
• Gaumet M , VargasA , GurnyR , DelieF. Nanoparticles for drug delivery: the need for precision in reporting particle size parameters. Eur. J. Pharm. Biopharm.69(1), 1–9 (2008).
   PubMed Web of Science ®Google Scholar
• Malinovskaya Y , MelnikovP , BaklaushevVet al. Delivery of doxorubicin-loaded PLGA nanoparticles into U87 human glioblastoma cells. Int. J. Pharm.524(1), 77–90 (2017).
   PubMed Web of Science ®Google Scholar
• Sahin A , EsendagliG , YerlikayaFet al. A small variation in average particle size of PLGA nanoparticles prepared by nanoprecipitation leads to considerable change in nanoparticles’ characteristics and efficacy of intracellular delivery. Artif. Cells Nanomed. Biotechnol.45, 1–11 (2017).
   Web of Science ®Google Scholar
• Xu R . Progress in nanoparticles characterization: Sizing and zeta potential measurement. Particuology6(2), 112–115 (2008).
   Web of Science ®Google Scholar
• Clogston JD , PatriAK. Zeta potential measurement. In: Characterization of Nanoparticles Intended for Drug Delivery. McNeilSE (Ed.). Methods Mol. Biol.Humana Press, NJ, USA, 63–70 (2011).
   Google Scholar
• Reichelt R . Scanning electron microscopy. In: Science of Microscopy. PWHawkes, JCHSpence ( Eds). Springer, NY, USA, 133–272 (2007).
   Google Scholar
• Tsapis N . Imaging polymer nanoparticles by means of transmission and scanning electron microscopy techniques. In: Polymer Nanoparticles for Nanomedicines. 205–219 (2016).
   Google Scholar
• Astete CE , SabliovCM. Synthesis and characterization of PLGA nanoparticles. J. Biomater. Sci., Polym. Ed.17(3), 247–289 (2006).
   PubMed Web of Science ®Google Scholar
• Çırpanlı Y , RobineauC , ÇapanY , ÇalışS. Etodolac loaded poly (lactide-co-glycolide) nanoparticles: formulation and in vitro characterization. Hacettepe Univ. J. Fac. Pharm.29(2), 105–114 (2009).
   Google Scholar
• Mittal G , SahanaD , BhardwajV , KumarMR. Estradiol loaded PLGA nanoparticles for oral administration: effect of polymer molecular weight and copolymer composition on release behavior in vitro and in vivo. J. Control. Release119(1), 77–85 (2007).
   PubMed Web of Science ®Google Scholar
• Chourasiya V , BohreyS , PandeyA. Formulation, optimization, characterization and in vitro drug release kinetics of atenolol loaded PLGA nanoparticles using 3 3 factorial design for oral delivery. Mater. Discov.5, 1–13 (2016).
   Google Scholar
• Vanza J , JaniP , PandyaN , TandelH. Formulation and statistical optimization of intravenous temozolomide-loaded PEGylated liposomes to treat glioblastoma multiforme by three-level factorial design. Drug Dev. Ind. Pharm.44, 1–11 (2018).
   PubMed Web of Science ®Google Scholar
• Pandya NT , JaniP , VanzaJ , TandelH. Solid lipid nanoparticles as an efficient drug delivery system of olmesartan medoxomil for the treatment of hypertension. Colloids Surf. B165 (2018).
   PubMed Web of Science ®Google Scholar
• Chalikwar SS , MeneBS , PardeshiCV , BelgamwarVS , SuranaSJ. Self-assembled, chitosan grafted PLGA nanoparticles for intranasal delivery: design, development and ex vivo characterization. Polym. Plast. Technol. Eng.52(4), 368–380 (2013).
   Web of Science ®Google Scholar
• Sharma D , MaheshwariD , PhilipGet al. Formulation and optimization of polymeric nanoparticles for intranasal delivery of lorazepam using Box-Behnken design: in vitro and in vivo evaluation. Biomed. Res. Int., 2014 (2014).
   Web of Science ®Google Scholar
• Patil GB , SuranaSJ. Fabrication and statistical optimization of surface engineered PLGA nanoparticles for naso-brain delivery of ropinirole hydrochloride: in vitro–ex vivo studies. J. Biomater. Sci. Polym. Ed.24(15), 1740–1756 (2013).
   PubMed Web of Science ®Google Scholar
• Mahajan HS , GattaniSG. Nasal administration of ondansetron using a novel microspheres delivery system Part II: ex vivo and in vivo studies. Pharm. Dev. Technol.15(6), 653–657 (2010).
   PubMed Web of Science ®Google Scholar
• Pardeshi CV , BelgamwarVS , TekadeAR , SuranaSJ. Novel surface modified polymer–lipid hybrid nanoparticles as intranasal carriers for ropinirole hydrochloride: in vitro, ex vivo and in vivo pharmacodynamic evaluation. J. Mater. Sci. Mater. Med.24(9), 2101–2115 (2013).
   PubMed Web of Science ®Google Scholar
• Javia A , ThakkarH. Intranasal delivery of tapentadol hydrochloride–loaded chitosan nanoparticles: formulation, characterisation and its in vivo evaluation. J. Microencapsulation34(7), 644–658 (2017).
   PubMed Web of Science ®Google Scholar
• Abelaira HM , ReusGZ , QuevedoJ. Animal models as tools to study the pathophysiology of depression. Revista brasileira de psiquiatria.35, S112–S120 (2013).
   PubMed Web of Science ®Google Scholar
• Deussing JM . Animal models of depression. Drug Discov. Today Dis. Models3(4), 375–383 (2007).
   Google Scholar
• Cryan JF , ValentinoRJ , LuckiI. Assessing substrates underlying the behavioral effects of antidepressants using the modified rat forced swimming test. Neurosci. Biobehav. Rev.29(4), 547–569 (2005).
   PubMed Web of Science ®Google Scholar
• Pardeshi CV , BelgamwarVS. Direct nose to brain drug delivery via integrated nerve pathways bypassing the blood–brain barrier: an excellent platform for brain targeting. Expert Opin. Drug Deliv.10(7), 957–972 (2013).
   PubMed Web of Science ®Google Scholar
• Costantino L , BoraschiD. Is there a clinical future for polymeric nanoparticles as brain-targeting drug delivery agents?Drug Discov. Today17(7–8), 367–378 (2012).
   PubMed Web of Science ®Google Scholar
• Taş Ç , OzkanY , SavaşerA , BaykaraT. Invitro and ex vivo permeation studies of chlorpheniramine maleate gels prepared by carbomer derivatives. Drug Dev. Ind. Pharm.30(6), 637–647 (2004).
   PubMed Web of Science ®Google Scholar
• Mehta P , Al-KinaniAA , QutachiOet al. Assessing the ex vivo permeation behaviour of functionalised contact lens coatings engineered using an electrohydrodynamic technique. J. Phys. Mater.2(1), 014002 (2018).
   Google Scholar
• Food and Drug Administration . Guidance for Industry Q1A (R2) Stability Testing of New Drug Substances and Products. Food and Drug Administration, MD, USA. ( Online) (2003). http://www.fda.gov/downloads/RegulatoryInformation/Guidances/ucm128204.pdf
   Google Scholar